TW200738231A - Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine - Google Patents

Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine

Info

Publication number
TW200738231A
TW200738231A TW096105363A TW96105363A TW200738231A TW 200738231 A TW200738231 A TW 200738231A TW 096105363 A TW096105363 A TW 096105363A TW 96105363 A TW96105363 A TW 96105363A TW 200738231 A TW200738231 A TW 200738231A
Authority
TW
Taiwan
Prior art keywords
migraine
treatment
benzo
fused heterocycle
sulfamide derivatives
Prior art date
Application number
TW096105363A
Other languages
Chinese (zh)
Other versions
TWI404528B (en
Inventor
Virginia L Smith-Swintosky
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of TW200738231A publication Critical patent/TW200738231A/en
Application granted granted Critical
Publication of TWI404528B publication Critical patent/TWI404528B/en

Links

Abstract

The present invention is the use of a therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) and formula (II) as herein defined for the manufacture of medicaments for the treatment or prevention of migraine. The present invention is directed to the use for the treatment and / or prevention of migraine, which includes mono-therapy and alternatively, co-therapy with at least anti-migraine agent.
TW96105363A 2006-02-15 2007-02-14 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine TWI404528B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77376406P 2006-02-15 2006-02-15

Publications (2)

Publication Number Publication Date
TW200738231A true TW200738231A (en) 2007-10-16
TWI404528B TWI404528B (en) 2013-08-11

Family

ID=38813279

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96105363A TWI404528B (en) 2006-02-15 2007-02-14 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine

Country Status (4)

Country Link
AR (1) AR059503A1 (en)
PE (1) PE20080108A1 (en)
TW (1) TWI404528B (en)
UY (1) UY30160A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849635B2 (en) * 2001-05-07 2005-02-01 Smithkline Beecham Corporation Sulfonamides
AR049646A1 (en) * 2004-06-16 2006-08-23 Janssen Pharmaceutica Nv USEFUL SULFAMATE AND SULFAMIDE DERIVATIVES FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS

Also Published As

Publication number Publication date
AR059503A1 (en) 2008-04-09
TWI404528B (en) 2013-08-11
UY30160A1 (en) 2007-07-31
PE20080108A1 (en) 2008-02-11

Similar Documents

Publication Publication Date Title
HK1141231A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
HK1125040A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
EA200601746A1 (en) APPLICATION OF ROTIGOTINE FOR THE TREATMENT AND PREVENTION OF THE PARKINSONISM-PLUS SYNDROME
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
MY150903A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
MY145823A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
MX2010008460A (en) Thiazole derivative and use thereof as vap-1 inhibitor.
TW200738651A (en) Cyclohexyl sulfonamide derivatives
MX2009004770A (en) Carbamate compounds for use in treating depression.
JO2999B1 (en) Tricyclic Compound And Pharmaceutical Use Therof
WO2007095611A3 (en) Use of benzo-fused heteroaryl sulfamide derivatives for the treatment of migraine
WO2007095609A3 (en) Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder
TW200738231A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
UA100552C2 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety and related disorders
TW200744580A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
JO2608B1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
TW200735880A (en) Medicinal compositions for preventing or treating heart failure
TW200744581A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
TW200744578A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
TW200800935A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
WO2008131858A3 (en) Use of acyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees